Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2 Dose-Rising, Safety, Tolerability and Efficacy Study of Topical SOR007 for Cutaneous Metastases

NCT03101358 is registered in ClinicalTrials.gov with NanOlogy, LLC as lead sponsor.

NCT NCT03101358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03101358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2 Dose-Rising, Safety, Tolerability and Efficacy Study of Topical SOR007 for Cutaneous Metastases
Lead sponsor
NanOlogy, LLC
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2018
Completion date
April 29, 2020
Enrollment
23 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous metastasis